Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor

Blood. 1995 Jul 15;86(2):540-7.

Abstract

The isolation and cloning of the ligand for the cytokine receptor, Mpl, have been recently described. In this report we present details of the purification of this novel cytokine (megakaryocyte growth and development factor [MGDF]) from aplastic canine plasma. Two forms of canine MGDF, with apparent molecular weights of 25 kD and 31 kD and sharing a common N-terminal amino acid sequence, were isolated. The sole contaminant detected in purified 25-kD or 31-kD MGDF was canine Ig. Canine MGDF is characterized as a human megakaryocyte colony-stimulating factor that acts synergistically with human recombinant stem cell factor but not interleukin-3. MGDF also appears to be physiologically regulated in response to platelet demand. In canine and murine models, serum levels of MGDF activity peak during the thrombocytopenic periods after irradiation, 5-fluorouracil, or antiplatelet antisera injections. These data indicate that the megakaryocyte-stimulating activity that accumulates in plasma in response to platelet losses is a novel cytokine that functions through an interaction with the Mpl cytokine receptor.

MeSH terms

  • Amino Acid Sequence
  • Anemia, Aplastic / physiopathology
  • Animals
  • Cells, Cultured
  • Dogs
  • Drug Synergism
  • Humans
  • Interleukin-3 / pharmacology
  • Megakaryocytes / drug effects*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Molecular Sequence Data
  • Molecular Weight
  • Radiation Injuries, Experimental / physiopathology
  • Recombinant Proteins / pharmacology
  • Stem Cell Factor
  • Thrombocytopenia / physiopathology
  • Thrombopoietin / isolation & purification*
  • Thrombopoietin / pharmacology

Substances

  • Interleukin-3
  • Recombinant Proteins
  • Stem Cell Factor
  • Thrombopoietin